Ryosuke Oki
Impact in
- Neurology top 10%
- Amyotrophic Lateral Sclerosis Research
- Neurological disorders and treatments
- Parkinson's Disease Mechanisms and Treatments
-
- Neurogenetic and Muscular Disorders Research
Papers in
- Co-authors
- Tetsuya Urasaki (15 shared papers)Takeshi Yuasa (8 shared papers)Yuishin Izumi (9 shared papers)Ryuji Kaji (7 shared papers)Yukinori Ozaki (4 shared papers)Yuji Miura (7 shared papers)Misa Onishi (1 shared paper)Hiroyasu Ueda (1 shared paper)
In The Last Decade
Ryosuke Oki
33 papers receiving 334 citations
Peers
Comparison fields: 5 of 50
- Neurology 137
- Genetics 54
- Neurology 16
- Cellular and Molecular Neuroscience 30
- Oncology 37
Countries citing papers authored by Ryosuke Oki
This map shows the geographic impact of Ryosuke Oki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryosuke Oki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryosuke Oki more than expected).
Fields of papers citing papers by Ryosuke Oki
This network shows the impact of papers produced by Ryosuke Oki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryosuke Oki. The network helps show where Ryosuke Oki may publish in the future.
Co-authors
The 25 scholars most cited alongside Ryosuke Oki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 54 | |
| 2 | 2019 | 37 | |
| 3 | 2018 | 36 | |
| 4 | 2022 | 32 | |
| 5 | 2013 | 26 | |
| 6 | 2017 | 20 | |
| 7 | 2019 | 14 | |
| 8 | 2017 | 12 | |
| 9 | 2021 | 12 | |
| 10 | 2022 | 10 | |
| 11 | 2018 | 9 | |
| 12 | 2016 | 8 | |
| 13 | 2022 | 7 | |
| 14 | 2015 | 6 | |
| 15 | 2022 | 6 | |
| 16 | 2023 | 6 | |
| 17 | 2017 | 4 | |
| 18 | 2024 | 4 | |
| 19 | 2025 | 4 | |
| 20 | 2015 | 3 |
About Ryosuke Oki
Ryosuke Oki is a scholar working on Neurology, Oncology, Pulmonary and Respiratory Medicine, Genetics and Cardiology and Cardiovascular Medicine, having authored 40 papers that have together received 335 indexed citations. Recurring topics across this work include Amyotrophic Lateral Sclerosis Research (8 papers), Renal cell carcinoma treatment (5 papers), Bladder and Urothelial Cancer Treatments (4 papers), Sarcoma Diagnosis and Treatment (3 papers), Cardiac tumors and thrombi (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Neurogenetic and Muscular Disorders Research (3 papers) and Thyroid Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Neurology (137 citations), Genetics (54 citations), Neurology (16 citations), Cellular and Molecular Neuroscience (30 citations) and Oncology (37 citations). Ryosuke Oki has collaborated with scholars based in Japan, Italy and India. Frequent co-authors include Tetsuya Urasaki, Takeshi Yuasa, Yuishin Izumi, Ryuji Kaji, Yukinori Ozaki, Yuji Miura, Misa Onishi, Hiroyasu Ueda, Masato Ishigami and Hisatoyo Hiraoka. Their work appears in journals such as Journal of the Neurological Sciences, Annals of Oncology, Parkinsonism & Related Disorders, Urologic Oncology Seminars and Original Investigations and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.